Experimental drug for Alzheimer’s disease shows promise
One small alcoholic drink a day is linked to an increased risk of atrial fibrillation
13 January 2021Weaker skin barrier leads to faster uptake of chemicals
13 January 2021Experimental drug for Alzheimer’s disease shows promise
Drug maker Eli Lilly on Monday announced promising results from a small study of an experimental Alzheimer’s disease drug called donanemab.
